Literature DB >> 29438097

Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage.

Kai-Feng Xu1, Xinlun Tian1, Yanli Yang1, Hongbing Zhang2.   

Abstract

Entities:  

Keywords:  lymphangioleiomyomatosis; rapamycin; sirolimus

Mesh：

Substances：

Year:  2018        PMID： 29438097     DOI： 10.1136/thoraxjnl-2017-211135

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

Review 1.  mTOR in Lung Neoplasms.

Authors:  Ildiko Krencz; Anna Sebestyen; Andras Khoor
Journal:  Pathol Oncol Res       Date:  2020-02-03       Impact factor: 3.201

Review 2.  Recent advances in the management of lymphangioleiomyomatosis.

Authors:  Kai-Feng Xu; Xinlun Tian; Jay H Ryu
Journal:  F1000Res       Date:  2018-06-18

3.  Total pleural coverage followed by lung transplantation in patient with lymphangioleiomyomatosis.

Authors:  Do Hyung Kim; Hyo Yeong Ahn; Bong Soo Son; Joohyung Son
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-10-14

4.  Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience.

Authors:  Eva Revilla-López; Cristina Berastegui; Alejandra Méndez; Berta Sáez-Giménez; Victoria Ruiz de Miguel; Manuel López-Meseguer; Victor Monforte; Carlos Bravo; Miguel Angel Pujana; Maria Antonia Ramon; Susana Gómez-Ollés; Antonio Roman
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

5.  Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome.

Authors:  Shuang Liu; Chen Li; Ming-Wei Tang; Wen-Shuai Xu; Ke-Qi Chen; Xin Sui; Xin-Lun Tian; Kai-Feng Xu
Journal:  Chin Med J (Engl)       Date:  2019-10-05       Impact factor: 2.628

6.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No 170: A 33-year-old psychologist with severe dyspnea and right-sided chylothorax.

Authors:  Philipp K Bauer; Martin Flicker; Elisabeth Fabian; Holger Flick; Luka Brcic; Bernadette Liegl-Atzwanger; Michael Janisch; Michael Fuchsjäger; Horst Olschewski; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2021-01       Impact factor: 1.704
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.